Discover 298 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Idaho provides a wide range of paid clinical research opportunities for both healthy volunteers and people with specific health conditions. Facilities in Boise, Idaho Falls, and Meridian are actively seeking participants, offering access to new therapies and specialized care.
Filter
1
Filter results
Results: 298
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for
Irritable Bowel Syndrome
Location: Boston MA, North Massapequa NY, Richmond Hill NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07519395
Phase 2, Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Berlin Corners VT, Burlington VT, Glens Falls NY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Sherbrooke, New York NY, Pasadena MD, Camp Hill PA,
Sponsor: Apollo Therapeutics Ltd
Sex: All
Age: 18 - 65
Code: NCT07599813
Phase 2, Recruiting
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
for
Pneumococcal Disease
Location: Baltimore MD, Columbia MD, East Syracuse NY,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07629440
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Brewer ME, Providence RI, West Islip NY, Stamford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07391774
Phase 3, Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
for
Focal Seizure, Epilepsy, Focal Epilepsy
Location: The Bronx NY, New York NY, Hackensack NJ, Livingston NJ,
Sponsor: Rapport Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT07563881
Phase 3, Recruiting
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
for
Pneumococcal Disease
Location: Fall River MA, Valhalla NY, Hawthorne NY, Sayre PA,
Sponsor: Pfizer
Sex: All
Age: 0
Code: NCT07573462
Phase 3, Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: New Brunswick NJ, Greenville NC, Wilmington NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07415044
Phase 2, Recruiting
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
for
Actinic Keratosis
Location: Plymouth Meeting PA, Aventura FL, North Miami Beach FL,
Sponsor: Sun Pharmaceutical Industries, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144852
Phase 3, Recruiting
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
for
Clostridioides Difficile Infection
Location: Halifax, Boston MA, Hamden CT, Quebec, Sherbrooke,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07285213
Phase 2, Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Halifax, Boston MA, Providence RI, New Haven CT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: New Brunswick NJ, Florham Park NJ, Tampa FL, Canton OH,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase 2, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Location: Baltimore MD, Columbus OH, St Louis MO, Idaho Falls ID,
Sponsor: Macro Biologics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07379684
Phase 1, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,